Picture of Haw Par logo

H02 Haw Par Share Price

0.000.00%
sg flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Momentum

Relative Strength (%)
1m+3.68%
3m+18.97%
6m+29.76%
1yr+36.7%
Volume Change (%)
10d/3m+98.79%
Price vs... (%)
52w High-3.08%
50d MA+3.1%
200d MA+14.85%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.69
Price to Tang. Book0.69
Price to Free Cashflow56.83
Price to Sales11.68
EV to EBITDA31.19

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5.83%
Return on Equity5.99%
Operating Margin98.81%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Haw Par EPS forecast chart

Profile Summary

Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing the Tiger trademarks and owning and holding investments for the long-term. Its segments include Healthcare products, Investments and Others. Its Healthcare products segment is engaged in manufacturing and distributing topical analgesic products under the Tiger Balm and Kwan Loong brands. Its Investments segment is engaged in long term investing activities, mainly in quoted securities in Asia. Its Others segment includes the property division, which owns and leases out several investment properties in Asia, and the leisure division, which provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand offers products such as Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch, and Tiger Balm Muscle Rub. Its Kwan Loong brand offers products such as Kwan Loong Medicated Oil and Kwan Loong Refresher.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
July 18th, 1969
Public Since
January 2nd, 1979
No. of Shareholders
19,258
No. of Employees
595
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
sg flag iconSingapore Exchange Securities Trading Ltd
Shares in Issue
221,368,173
Blurred out image of a map
Address
401 Commonwealth Drive, 149598
Web
https://www.hawpar.com/
Phone
+65 63379102
Auditors
PricewaterhouseCoopers LLP

H02 Share Price Performance

Upcoming Events for H02

Haw Par Corporation Ltd Annual Shareholders Meeting

Dividend For HPAR.SI - 1.0000 SGD

Dividend For HPAR.SI - 0.2000 SGD

Dividend For HAWPY.PK - 2.9700 USD

Dividend For HAWPY.PK - 0.5940 USD

Half Year 2025 Haw Par Corporation Ltd Earnings Release

Similar to H02

Picture of Hyphens Pharma International logo

Hyphens Pharma International

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of IX Biopharma logo

IX Biopharma

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of Pharmesis International logo

Pharmesis International

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of Suntar Eco-City logo

Suntar Eco-City

sg flag iconSingapore Exchange Securities Trading Ltd

FAQ